Lab News

[bioRxiv] Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1

|2025-04-30

[Trends Immunol] Deciphering SARS-CoV-2 evolution under antibody immune pressure

|2025-03-27

[LancetID] Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1

|2025-01-28

Prof. Yunlong Cao interviewed by Nature regarding viral evolution prediction with AI tools

|2025-01-08

Prof. Yunlong Cao interviewed by Science regarding SA55 nasal spray—a broadly neutralizing antibody against SARS-CoV-2 identified by Cao Lab

|2025-01-02

[Pharmaceutics] Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial

|2024-12-31

[bioRxiv] Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1

|2024-12-27

Prof. Yunlong Cao included in 2024 DAMO Academy Young Fellow list

|2024-12-20

[Cell Discov] Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2

|2024-11-30

[LancetID] Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations

|2024-11-22

[Nature] Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1

|2024-11-07

[Emerg Microbes Infec] Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain

|2024-10-28

[Emerg Microbes Infec] Prolonged Omicron-specific B cell maturation alleviates immune imprinting induced by SARS-CoV-2 inactivated vaccine

|2024-10-15

[Nat Immunol | News & Views] The delivery device of SARS-CoV-2 mucosal vaccine matters

|2024-09-03

Prof. Yunlong Cao awarded 2024 Xplorer Prize

|2024-08-26

[bioRxiv] Humoral immunogenicity comparison of XBB and JN.1 in human infections

|2024-04-23

[bioRxiv] A generalized framework to identify SARS-CoV-2 broadly neutralizing antibodies

|2024-04-19

[PLOS Pathogens] SARS-CoV-2 RBD L455F+F456L synergistically enhances ACE2 binding and immune evasion

|2023-12-22

[LancetID] Fast evolution of SARS-CoV-2 BA.2·86 to JN.1 under heavy immune pressure

|2023-12-18

[Nature] Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting

|2023-11-22

Updates on emerging variants JN.1, JD.1.1, HV.1

|2023-10-20

Perspectives on emerging SARS-CoV-2 BA.2.86

|2023-09-04

Perspectives on emerging XBB*+F456L variants

|2023-08-07

Nature reports on our research findings concerning protection from previous Omicron infection against XBB sublineages

|2023-06-09

[bioRxiv] Repeated Omicron infection alleviates SARS-CoV-2 immune imprinting

|2023-05-04

Perspectives on emerging XBB*+K478 mutants

|2023-04-22